UK pharma to receive parallel scientific advice from MHRA, NICE
This article was originally published in SRA
Executive Summary
The UK Medicines and Healthcare products Regulatory Agency and the National Institute for Health and Clinical Excellence, the country’s health technology assessment body, will offer parallel scientific advice to pharmaceutical companies under a new pilot programme1.